白细胞介素-6、白细胞介素-10、肿瘤坏死因子-α与冠心病关系的初步研究被引量：25

The Preliminary Study of the Relationship between IL-6,IL-10,TNF-α and Coronary Artery Disease

下载PDF

导出

摘要目的研究炎症细胞因子白细胞介素(IL)-6、肿瘤坏死因子(TNF)-α、IL-10等与冠心病(CHD)发病的关系。方法选取冠心病患者628例,同期经冠脉造影证实冠脉无狭窄的非冠心病患者540例为对照组,记录患者的资料,包括年龄、体质指数(BMI)、血糖(Glu)、总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)等指标,同时用酶联免疫吸附试验法检测血清IL-6、IL-10、TNF-α等炎症因子水平。结果CHD组BMI、LDL-C、TG水平均高于对照组,而HDL-C水平低于对照组(均P<0.05)。CHD组血清IL-6、TNF-α水平均高于对照组,而IL-10低于对照组(均P<0.05)。结论血清IL-6、TNF-α参与了CHD的发生。血清IL-10有抑制炎症作用,可能对血管有保护作用。 Objective To study the relationship between coronary artery disease （CHD ） and interleukin-6 （IL-6）, TNF-α and IL-10. Methods Patients with CHD were included in CHD group （n=628） and patients without CHD confirmed by coronary angiography were selected in control group （n=540） . The recorded data included age, body mass index （BMI） and serum levels of glucose （GLU）, total cholesterol （TC）, triglyceride （TG）, high density lipoprotein-cholesterol （HDL-C） and low density lipoprotein-cholesterol （LDL-C）. Meanwhile serum levels of IL-6, TNF-α, IL-10 were determined by ELISA. Results Serum levels of BMI, LDL-C, TG were higher in CHD group than those in control group（P〈0.01）. The serum level of HDL-C was significantly lower in CHD group than that in control group（P〈0.01）. Serum levels of IL-6（P〈0.05）and TNF-α（P〈0.01）were higher in CHD group than those in control group. The serum level of IL-10 was significantly lower in CHD group than that in control group（P〈0.01）. Conclusion IL-6 and TNF-αare involved in the development of CHD. IL-10 can inhibit inflammation and protect vessel integrity.

作者董军姜华陈树涛

机构地区天津市胸科医院CICU科天津市胸科医院心内一科

出处《天津医药》 CAS 北大核心 2014年第11期1112-1113,共2页 Tianjin Medical Journal

关键词冠心病白细胞介素6 白细胞介素10 肿瘤坏死因子Α coronary disease interleukin-6 interleukin-10 tumor necrosis factor-alpha

分类号 R541.4 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献6

1Esmon CT,Molecular circuits in thrombosis and inflammation[J]. Thromb Haemost,2013,109(3):416-420.
2Zhang C, Li Y,Wu Y,et al.Interleukin-6/signal transducer and acti- vator of transcription 3 (stat3)pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration [J]. J Biol Chem,2013,288(3):1489-1499.
3王卫定,李广平.C反应蛋白、白细胞介素-6与冠状动脉狭窄程度的相关性分析[J].天津医药,2012,40(7):707-710. 被引量：5
4Saia RS, Bertozi G, Mestriner F1, et al. Cardiovascular and inflam- matory response to eholecystokinin during endotoxemic shock [J]. Shock,2013,39(1):104-113.
5Almer G, Frascione D, Pali-Scholl I, et al. Interleukin-10:an antiin- flammatory marker to target atherosclerotie lesions via PEGylated li- posomes[J].Mol Pharm,2013,10(1): 175-186.
6Duerrschmid C, Crawford JR, Reineke E, et al. TNFreeeptor 1 sig- naling is critically involved in mediating angiotensin-II-induced cardiac fibrosis[J]. J Mol Cell Cardio,2013,57:59-67.

二级参考文献8

1Tanindi A, Sahinarslan A, Elbeg S, et al. Relationship BetweenMMP-1, MMP-9, TIMP-1, IL-6 and Risk Factors, Clinical Presen- tation, Extent and Severity of Atheroselerotic Coronary Artery Dis- ease[J]. Open Cardiovasc Med J, 2011, 5:110-116.
2Koc M, Karaarslan O, Abali G, et al. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coro- nary artery disease [J]. Tex Heart lnst, 2010, 37(1): 42-48.
3Su G, Mi S, Tao H, et al. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes [J]. Cardiovasc Diabetol, 2011, 10: 19.
4Gensini GG. A moremeaningful scoring system for determining the severity of coronary of coronary heart disease (letter) [J]. Am J Car- dlol, 1983, 51(3): 606.
5Zieske AW, Traey RP, McMallan CA, et al. Elevated Serum C-Re- active Protein Levels and Advanced Atherosclemsis in Youth [J]. Artdloscler Thromb Vase Bid, 2005, 25(6): 1237-1243.
6Alber HF, Wanitsehek MM, De Waha S, et al. AI.High-density lipo- protein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography [J]. Eur Clin Invest, 2008, 38(6): 372-380.
7Kincl V, Panovsky R, Meluzin J, et al. Association between laberato- ry markers and presence of coronary artery disease [J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2010, 154(3): 227-233.
8Brunetti ND, Troecoli R, Correale M, et al. C-reactive protein in pa- tients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. Int J Cardiol, 2006, 109(2): 248-256.